NASDAQ: CRKNCrown Electrokinetics Corp Stock
$1.14-0.05 (-4.2%)
Updated Oct 7, 2024
CRKN Price
$1.14
Fair Value Price
N/A
Market Cap
$5.00M
52 Week Low
$1.06
52 Week High
$90.00
P/E
0x
P/B
0.57x
P/S
1.43x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.42M
Earnings
-$21.81M
Gross Margin
-20%
Operating Margin
-293.31%
Profit Margin
-512.5%
Debt to Equity
0.82
Operating Cash Flow
-$17M
Beta
0.96
Next Earnings
Nov 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A
CRKN Overview
Crown Electrokinetics Corp. offers optical switching films and electrokinetic film technology for smart or dynamic glass. Known as 3D Nanocolor Corp. until 2017/10, Crown ElectroKinetics was incorporated in 2015 and is based in Corvallis, OR.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRKN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CRKN is good value based on its earnings relative to its share price (0x), compared to the US market average (26.63x)
P/E vs Market Valuation
CRKN is good value based on its earnings relative to its share price (0x), compared to the US Specialty Chemicals industry average (32.9x)
P/E vs Industry Valuation
CRKN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more CRKN due diligence checks available for Premium users.
Be the first to know about important CRKN news, forecast changes, insider trades & much more!
CRKN News
Valuation
CRKN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
32.9x
Market
26.63x
CRKN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CRKN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CRKN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.57x
Industry
3.61x
CRKN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CRKN's financial health
Profit margin
Revenue
$4.6M
Net Income
-$5.0M
Profit Margin
-220.6%
CRKN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CRKN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$16.0M
Liabilities
$7.2M
Debt to equity
0.82
CRKN's short-term assets ($9.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRKN's short-term assets ($9.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRKN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CRKN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$6.2M
Investing
$7.0k
Financing
$9.9M
CRKN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CRKN vs Specialty Chemical Stocks
Crown Electrokinetics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.